GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Laboratorio Reig Jofre SA (XMAD:RJF) » Definitions » Enterprise Value

Laboratorio Reig Jofre (XMAD:RJF) Enterprise Value : €269.4 Mil (As of May. 15, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Laboratorio Reig Jofre Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Laboratorio Reig Jofre's Enterprise Value is €269.4 Mil. Laboratorio Reig Jofre's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €4.1 Mil. Therefore, Laboratorio Reig Jofre's EV-to-EBIT ratio for today is 65.95.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Laboratorio Reig Jofre's Enterprise Value is €269.4 Mil. Laboratorio Reig Jofre's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was €15.6 Mil. Therefore, Laboratorio Reig Jofre's EV-to-EBITDA ratio for today is 17.26.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Laboratorio Reig Jofre's Enterprise Value is €269.4 Mil. Laboratorio Reig Jofre's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was €158.9 Mil. Therefore, Laboratorio Reig Jofre's EV-to-Revenue ratio for today is 1.70.


Laboratorio Reig Jofre Enterprise Value Historical Data

The historical data trend for Laboratorio Reig Jofre's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Laboratorio Reig Jofre Enterprise Value Chart

Laboratorio Reig Jofre Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 236.84 380.02 312.97 224.34 224.33

Laboratorio Reig Jofre Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 230.95 224.34 254.43 241.53 224.33

Competitive Comparison of Laboratorio Reig Jofre's Enterprise Value

For the Drug Manufacturers - Specialty & Generic subindustry, Laboratorio Reig Jofre's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Laboratorio Reig Jofre's Enterprise Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Laboratorio Reig Jofre's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Laboratorio Reig Jofre's Enterprise Value falls into.



Laboratorio Reig Jofre Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Laboratorio Reig Jofre's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as

Laboratorio Reig Jofre's Enterprise Value for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Laboratorio Reig Jofre  (XMAD:RJF) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Laboratorio Reig Jofre's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=269.352/4.084
=65.95

Laboratorio Reig Jofre's current Enterprise Value is €269.4 Mil.
Laboratorio Reig Jofre's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €4.1 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Laboratorio Reig Jofre's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=269.352/15.602
=17.26

Laboratorio Reig Jofre's current Enterprise Value is €269.4 Mil.
Laboratorio Reig Jofre's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €15.6 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Laboratorio Reig Jofre's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=269.352/158.897
=1.70

Laboratorio Reig Jofre's current Enterprise Value is €269.4 Mil.
Laboratorio Reig Jofre's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €158.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Laboratorio Reig Jofre Enterprise Value Related Terms

Thank you for viewing the detailed overview of Laboratorio Reig Jofre's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Laboratorio Reig Jofre (XMAD:RJF) Business Description

Traded in Other Exchanges
Address
Avenida de les Flors, Sant Joan Despi, Barcelona, ESP, 08970
Laboratorio Reig Jofre SA is a healthcare and pharmaceutical developing company. The company focuses on the development of technological-specialization products (antibiotics and injectable products); therapeutic-specialization products in the areas of dermatology, gynecology and respiratory; and consumer healthcare products. It has a broad portfolio of products that the company divides into three categories: products from specialized technology such as antibiotics, injectable, and freeze-dried products.